Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$401,409,396
-$207,372,228 QoQ
Shares Held
7,657,562
-30.6% QoQ
Ownership
0.382%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#7
of 1,032 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. GSK ranks #14 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $401,409,396 | 7,657,562 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $608,781,624 | 11,030,651 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $285,837,629 | 5,828,663 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $213,608,677 | 4,949,228 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $198,691,387 | 5,174,255 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $205,923,319 | 5,315,522 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $193,686,933 | 5,726,994 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $325,152,689 | 7,953,833 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $389,177,979 | 10,108,519 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $534,633,350 | 12,471,037 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $316,943,526 | 8,552,173 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $273,743,865 | 7,551,555 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $263,560,468 | 7,395,075 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $199,465,032 | 5,606,100 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $179,431,652 | 5,106,194 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $148,063,768 | 5,031,049 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $333,084,322 | 7,801,625 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $180,072,826 | 4,214,828 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $186,457,318 | 4,310,825 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $159,734,660 | 4,262,277 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $164,991,765 | 4,224,551 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $139,603,185 | 3,988,121 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $136,948,399 | 3,794,274 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $124,692,577 | 3,377,618 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $131,940,130 | 3,297,940 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $167,353,939 | 4,503,300 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||